Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab

AIMS: Guidelines recommend targeting non-high-density lipoprotein cholesterol to reduce cardiovascular risk. We assessed the impact of baseline triglycerides on non-high-density lipoprotein cholesterol goal attainment in 10 phase 3 trials with alirocumab versus control (n = 4983). METHODS: Trials we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Prev Cardiol
Autors principals: Vallejo-Vaz, Antonio J, Leiter, Lawrence A, Del Prato, Stefano, Taskinen, Marja-Riitta, Müller-Wieland, Dirk, Bujas-Bobanovic, Maja, Letierce, Alexia, Mandel, Jonas, Samuel, Rita, Ray, Kausik K
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Full Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7549294/
https://ncbi.nlm.nih.gov/pubmed/32089006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2047487320905185
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars